Lexeo Therapeutics Inc. Common Stock (LXEO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lexeo Therapeutics Inc. C...

    NASDAQ: LXEO · Real-Time Price · USD
    5.18
    0.00 (0.00%)
    At close: Sep 12, 2025, 3:59 PM
    5.18
    0.00%
    After-hours: Sep 12, 2025, 05:42 PM EDT

    Lexeo Therapeutics Common Stock Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 654K 1.66M
    Cost of Revenue
    		 2M 1.84M 1.15M 13.4K
    Gross Profit
    		 -2M -1.84M -491K 1.64M
    Operating Income
    		 -105.77M -68.51M -60.51M -50.64M
    Interest Income
    		 7.56M 2.87M 1.32M 15K
    Pretax Income
    		 -98.33M -66.39M -59.28M -50.62M
    Net Income
    		 -98.33M -66.39M -59.28M -50.62M
    Selling & General & Admin
    		 31.68M 13.54M 12M 7.16M
    Research & Development
    		 74.09M 53.13M 49.16M 45.12M
    Other Expenses
    		 n/a n/a -2K n/a
    Operating Expenses
    		 105.77M 66.67M 61.16M 52.29M
    Interest Expense
    		 114K 205K 91K n/a
    Selling & Marketing Expenses
    		 n/a -1.84M n/a -13.38K
    Cost & Expenses
    		 105.77M 68.51M 61.16M 52.29M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 31.79M 26.65M 25.17M 25.17M
    Shares Outstanding (Diluted)
    		 31.79M 26.65M 25.17M 25.17M
    EPS (Basic)
    		 -3.09 -2.49 -2.36 -2.01
    EPS (Diluted)
    		 -3.09 -2.49 -2.4 -2.01
    EBITDA
    		 -96.22M -66.67M -58.04M -50.62M
    EBIT
    		 -98.22M -66.19M -59.19M -50.62M
    Depreciation & Amortization
    		 2M 1.84M 1.15M 13K

    Add to Watchlist